Advanced search×
×

Seminars in Nuclear Medicine

Print ISSN
0001-2998
Electronic ISSN
1558-4623
Impact factor
4.571
Publisher
Sciencedirect
URL
http://www.sciencedirect.com/science/journal/00012998
Usage rank
3853
Article count
1392
Free count
9
Free percentage
0.00646552
PDFs via platforms
Gale, Sciencedirect from 1971, Proquest, and CSA

  1. Perspectives in molecular imaging through translational research, human medicine, and veterinary medicine.

    Seminars in Nuclear Medicine 44(1):66 (2014) PMID 24314047

    The concept of molecular imaging has taken off over the past 15 years to the point of the renaming of the Society of Nuclear Medicine (Society of Nuclear Medicine and Molecular Imaging) and Journals (European Journal of Nuclear Medicine and Molecular Imaging) and offering of medical fellowships spec...
  2. PET/CT imaging of inflammatory bowel disease.

    Seminars in Nuclear Medicine 43(6):420 (2013) PMID 24094709

    PET/CT imaging has become an important part of the evaluation of patients with many types of cancer. This imaging modality can also be used to image areas of active inflammation, such as those occurring in patients with active inflammatory bowel disease (IBD) (Crohn's disease and ulcerative colitis)...
  3. Letter from the editors.

    Seminars in Nuclear Medicine 43(3):157 (2013) PMID 23561450

  4. In Memoriam: Alexander Gottschalk, MD (1932-2010)

    Seminars in Nuclear Medicine 41(2):2 (2011) PMID 21272680

  5. Design of Clinical Trials

    Seminars in Nuclear Medicine 40(5):6 (2010) PMID 20674592

    Clinical trial design for nuclear medicine diagnostic imaging radiopharmaceuticals must include a design for preclinical safety studies. These studies should establish that the investigational product (IP) does not have a toxic effect. As a further requirement, radiopharmaceutical cl...
  6. Immuno-positron emission tomography in cancer models.

    Seminars in Nuclear Medicine 40(3):182 (2010) PMID 20350627 PMCID PMC2848398

    Positron emission tomography (PET) is playing an increasingly important role in the diagnosis, staging, and monitoring response to treatment in a variety of cancers. Recent efforts have focused on immuno-PET, which uses antibody-based radiotracers, to image tumors based on expression of tumor-associ...
  7. Seminars in Nuclear Medicine. Selected pharmacologic interventions and monitoring. Letter from the editors.

    Seminars in Nuclear Medicine 39(3):155 (2009) PMID 19341835

  8. Risks to normal tissues from radionuclide therapy.

    Seminars in Nuclear Medicine 38(5):347 (2008) PMID 18662556

    The development of radionuclide therapies during the past few decades provides a growing body of data on radiobiologic effects, including normal tissue toxicities and antitumor efficacy. Information on normal tissue toxicity from radionuclides is more limited than that from external beam radiation a...
  9. Developments in instrumentation. Letter from the editors.

    Seminars in Nuclear Medicine 38(3):149 (2008) PMID 18396174

  10. Use of the Oak Ridge National Laboratory tungsten-188/rhenium-188 generator for preparation of the rhenium-188 HDD/lipiodol complex for tran...

    Seminars in Nuclear Medicine 38(2):S19 (2008) PMID 18243839

    This work describes the installation, use, and quality control (QC) of the alumina-based tungsten-188 ((188)W)/rhenium-188 ((188)Re) generators provided by the Oak Ridge National Laboratory (ORNL). In addition, methods used for concentration of the (188)Re-perrhenate bolus and preparation of (188)Re...